Loading
NASDAQHealthcareDrug Manufacturers - Specialty & Generic
Latest quote
$35.07
−$1.06 · -2.93%
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Regular session
$35.30
−$0.83 · -2.30%
Regular session · ET · Market data may be delayed.
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Day range
Current $35.30
52-week range
Current $35.30
Regular session · ET · Market data may be delayed.
GoAI Score
Buy
Valuation
71
Undervalued
Sentiment
55
Mixed
Risk
30
Moderate Risk
Momentum
60
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Day range
Current $35.30
52-week range
Current $35.30
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.24B USD | 1.19B USD | 1.09B USD | 901M USD | 791M USD |
| Cost of goods sold | 246M USD | 231M USD | 174M USD | 151M USD | 127M USD |
| Gross profit | 993M USD | 957M USD | 919M USD | 750M USD | 664M USD |
| Research and development | 97M USD | 107M USD | 116M USD | 74M USD | 52M USD |
| Selling, general, and administrative | 634M USD | 618M USD | 569M USD | 469M USD | 431M USD |
| Operating expenses | 728M USD | 925M USD | 1.08B USD | 831M USD | 451M USD |
| Interest income | 22M USD | 23M USD | 43M USD | 19M USD | 4M USD |
| Interest expense | 45M USD | 41M USD | 35M USD | 29M USD | 26M USD |
| Depreciation and amortization | 20M USD | 28M USD | 15M USD | 16M USD | 22M USD |
| Operating income | 265M USD | 32M USD | −156M USD | −81M USD | 213M USD |
| Net income | 210M USD | 2M USD | −129M USD | −44M USD | 205M USD |
Company facts updated Oct 8, 2026.
Reported history and fiscal-year consensus
Reported history and fiscal-year consensus
Third-party consensus; not a GoAI recommendation.
Average target
$48.00
35.98% upsideLimited analyst sample: 4 ratings. Interpret the distribution with caution.
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core S&P Small-Cap ETFIJR254.87M0.25%104.29B USD0.06%$137.14+0.04%
Vanguard Morningstar Total Stock Market ETFVTI135.62M0.01%2.3T USD0.03%$378.97-0.54%
iShares Russell 2000 ETFIWM113.51M0.15%78.56B USD0.19%$277.11-0.21%
Vanguard Morningstar Small-Cap ETFVB97.99M0.05%185.3B USD0.03%$286.86-0.04%
Vanguard Morningstar Small-Cap Growth ETFVBK56.32M0.12%44.7B USD0.05%$338.68-1.04%
Vanguard Extended Market ETFVXF49.49M0.05%95.4B USD0.05%$232.31-0.51%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM39.84M0.25%16.01B USD0.03%$53.31+0.06%
iShares Russell 2000 Growth ETFIWO35.96M0.26%14.25B USD0.24%$352.56-0.79%iShares Core S&P Small-Cap ETFIJRVanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Morningstar Small-Cap ETFVBVanguard Morningstar Small-Cap Growth ETFVBKVanguard Extended Market ETFVXFState Street SPDR Portfolio S&P 600 Small Cap ETFSPSMiShares Russell 2000 Growth ETFIWOAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
